No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
SGMO250117C1500
- 0.95
- -0.05-5.00%
15min DelayClose Dec 23 16:00 ET
0.95High0.95Low
0.95Open1.00Pre Close1 Volume197 Open Interest1.50Strike Price95.00Turnover139.46%IV2.51%PremiumJan 17, 2025Expiry Date0.89Intrinsic Value100Multiplier24DDays to Expiry0.06Extrinsic Value100Contract SizeAmericanOptions Type0.9307Delta0.1547Gamma2.58Leverage Ratio-0.0025Theta0.0009Rho2.40Eff Leverage0.0008Vega
Intraday
- 5D
- Daily
News
Sector Update: Health Care Stocks Mixed Premarket Thursday
Sangamo Shares Rally Premarket on License Deal With Astellas
Why Sangamo Therapeutics Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
Biggest Stock Movers Thursday: MU, MESO, and More
Express News | Sangamo Therapeutics Inc - Eligible for up to $1.3 Billion in Milestone Payments
Express News | Sangamo Therapeutics and Astellas Announce Capsid License Agreement to Deliver Genomic Medicines for Neurological Diseases